| Not Yet Recruiting | A Study to Assess Intravenous (IV) Telisotuzumab Adizutecan in Combination With Fluorouracil, Folinic Acid, an Metastatic Pancreatic Ductal Adenocarcinoma, PDAC | Phase 2 / Phase 3 | 2026-06-03 |
| Not Yet Recruiting | A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Sta Colorectal Cancer | Phase 3 | 2026-05-07 |
| Not Yet Recruiting | A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of C Small Cell Lung Cancer | Phase 3 | 2026-04-14 |
| Recruiting | A Study to Assess Adverse Events, Tolerability, and Pharmacokinetics of Subcutaneous Injections of ABBV-295 in Healthy Volunteer | Phase 1 | 2026-03-31 |
| Recruiting | A Phase 1 Study to Assess the Effect of ABBV-722 on Ethinyl Estradiol and Levonorgestrel Drug Levels in Health Healthy Volunteer | Phase 1 | 2026-03-25 |
| Recruiting | Study to Assess Change in Disease Activity of Oral Venetoclax in Adult Participants With Recurring Relapsed or Waldenstrom Macroglobulinemia, Lymphoplasmacytic Lymphoma | Phase 2 | 2026-03-17 |
| Recruiting | A Study to Assess Change in Disease Symptoms in Adult Participants With Advanced Parkinson Disease Using Subcu Parkinson's Disease | — | 2026-03-09 |
| Not Yet Recruiting | A Study to Assess How Intravenous and Subcutaneous Administrations of Risankizumab Moves Through the Body of H Healthy Volunteer | Phase 1 | 2026-03-08 |
| Not Yet Recruiting | Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants Earlier Parkinson's Disease | — | 2026-03-01 |
| Not Yet Recruiting | A Study to Evaluate Folate Receptor Alpha (FRα) Expression in Adult Participants With Ovarian, Fallopian Tube, Cancer - Ovarian | — | 2026-02-28 |
| Recruiting | Study of Glecaprevir/Pibrentasvir to Assess Safety Through Real-World Data Hepatitis C Virus (HCV) | — | 2026-02-27 |
| Recruiting | A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Mov Multiple Myeloma | Phase 1 | 2026-02-27 |
| Recruiting | A Phase 1 Study of the Safety and How the Body Processes ABBV-722 and Upadacitinib After Multiple Oral Doses i Healthy Volunteer | Phase 1 | 2026-02-26 |
| Recruiting | A Study of ABBV-295 Subcutaneous Injections to Assess Pharmacokinetics and Adverse Events in Healthy Adult Wom Healthy Volunteer | Phase 1 | 2026-02-11 |
| Recruiting | A Study to Assess How the Body Absorbs ABBV-8736 Subcutaneous Injections Relative to Intravenous Injections in Healthy Volunteer | Phase 1 | 2026-02-11 |
| Recruiting | A Retrospective Study to Evaluate Treat-to-Target and Disease Modification in Adult Participants With Crohn's Crohn's Disease, Ulcerative Colitis | — | 2026-02-09 |
| Recruiting | Study of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants Undergoin Ventral Hernia | Phase 2 | 2026-02-04 |
| Recruiting | A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I Disorder, Bipolar II Disorder | Phase 2 | 2026-02-03 |
| Recruiting | Study to Assess the Real-World Effectiveness of Ubrogepant in Adult Participants When Treating During the Prod Migraine | — | 2026-01-27 |
| Recruiting | Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathi Idiopathic Pulmonary Fibrosis | Phase 2 | 2026-01-23 |
| Active Not Recruiting | A Phase 1 Study of a Tablet Form of ABBV-722 Taken With and Without Food in Healthy Adult Participants Healthy Volunteers | Phase 1 | 2026-01-15 |
| Not Yet Recruiting | A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatr Acute Myeloid Leukemia | Phase 1 | 2026-01-14 |
| Recruiting | A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Et Multiple Myeloma | Phase 2 / Phase 3 | 2026-01-08 |
| Recruiting | A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder | Phase 2 | 2025-12-18 |
| Recruiting | A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of ABBV-243 in Healthy Adults. Healthy Volunteers | Phase 1 | 2025-12-17 |
| Recruiting | A Clinical Study to Evaluate the Effect and Side Effect of a New Artificial Tear Formulation (ABBV-444) Compar Dry Eye Disease | Phase 3 | 2025-12-15 |
| Recruiting | A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan C Non-Small Cell Lung Cancer | Phase 2 / Phase 3 | 2025-12-10 |
| Recruiting | A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through th Ovarian Cancer | Phase 1 | 2025-11-27 |
| Recruiting | A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Small Cell Lung Cancer | Phase 2 | 2025-11-25 |
| Recruiting | A Study to Evaluate How the Study Drug Moves Through the Body, Adverse Events, and How the Body Tolerates ABBV Healthy Volunteer | Phase 1 | 2025-11-24 |
| Recruiting | A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer | Phase 2 | 2025-11-21 |
| Recruiting | A Study to Assess the Adverse Events, Change in Disease Activity, and How Oral ABBV-711 Tablets Move Through t Advanced Squamous Tumors | Phase 1 | 2025-11-20 |
| Recruiting | A Study of ABBV-295 Subcutaneous Injections to Assess Adverse Events and Pharmacokinetics in Adult Participant Obesity | Phase 1 | 2025-11-19 |
| Recruiting | A Study to Assess Change in Sleep Disturbances of Adult Participants With Advanced Parkinson's Disease Receivi Advanced Parkinson's Disease | — | 2025-11-17 |
| Recruiting | A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intrav Ovarian Cancer | Phase 2 | 2025-11-13 |
| Recruiting | Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation o Neovascular Age-related Macular Degeneration | Phase 3 | 2025-11-05 |
| Recruiting | A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Solid Tumors Harboring MET Amplification | Phase 2 | 2025-10-29 |
| Recruiting | A Study to Assess the Adverse Events and How Oral ABBV-1042 Moves Through the Body of Healthy Adult Participan Healthy Volunteer | Phase 1 | 2025-10-27 |
| Recruiting | A Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne Scars | Phase 3 | 2025-10-24 |
| Completed | A Study to Assess the Mass Balance of Oral ABBV-1354 in Healthy Adult Male Participants Healthy Volunteer | Phase 1 | 2025-10-15 |
| Not Yet Recruiting | A Mass Balance Study of Oral [14C] ABBV-932 in Healthy Adult Male Participants Healthy Volunteer | Phase 1 | 2025-10-14 |
| Recruiting | Study to Assess Change in Disease Activity of Risankizumab Treatment in Japanese Participants With Moderate to Ulcerative Colitis | — | 2025-10-09 |
| Recruiting | A Study to Assess the Adverse Events and How Oral Emraclidine Moves Through the Body of Healthy Elderly Adult Healthy Volunteer | Phase 1 | 2025-10-08 |
| Recruiting | Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated Bipolar I or II Disorder | Phase 2 | 2025-09-30 |
| Active Not Recruiting | A Study to Evaluate the Safety and Effectiveness of JUVÉDERM Products in Adult Participants for the Change of Mid Face Volume Deficit | Phase 4 | 2025-09-25 |
| Withdrawn | A Study to Assess Adverse Events and Change in Disease Condition of Mesalamine Capsules in Children Aged 5 to Ulcerative Colitis (UC) | Phase 3 | 2025-09-15 |
| Recruiting | Study to Assess Change in Quality of Life of Risankizumab Treatment in Adult Participants With Moderate-to-Sev Plaque Psoriasis | — | 2025-09-09 |
| Active Not Recruiting | A Study to Evaluate Adverse Events, How the Drug is Tolerated, and How the Drug Moves Through the Body of Intr Healthy Volunteer | Phase 1 | 2025-09-02 |
| Recruiting | A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata Non-Segmental Vitiligo (NSV), Alopecia Areata, Hidradenitis Suppurativa | — | 2025-09-02 |
| Recruiting | A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusio Dry Eye Syndrome, Systemic Lupus Erythematosus | Phase 1 | 2025-08-26 |
| Completed | Study to Assess the Adverse Events, Tolerability, and How Oral Doses of ABBV-932 Moves Through the Body in Hea Healthy Volunteer | Phase 1 | 2025-08-21 |
| Recruiting | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of ABBV-277 in Healthy Adult Healthy Volunteers | Phase 1 | 2025-08-19 |
| Recruiting | Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants Geographic Atrophy, Age-Related Macular Degeneration | Phase 1 / Phase 2 | 2025-08-13 |
| Recruiting | A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Colorectal Cancer | Phase 2 | 2025-08-07 |
| Recruiting | Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug ( Multiple Myeloma | Phase 1 | 2025-08-07 |
| Recruiting | A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body Schizophrenia | Phase 2 | 2025-08-04 |
| Recruiting | A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combin Non-Squamous Non-Small Cell Lung Cancer | Phase 2 / Phase 3 | 2025-08-03 |
| Recruiting | A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Gynecologic Cancers, Platinum-Sensitive Ovarian Cancer, Fallopian Tube Cancer | Phase 2 | 2025-07-30 |
| Recruiting | A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis Ulcerative Colitis | Phase 3 | 2025-07-28 |
| Recruiting | Study to Assess Adverse Events and Change in Disease Activity of Oral Venetoclax in Combination With Subcutane Acute Myeloid Leukemia | Phase 4 | 2025-07-24 |
| Recruiting | A Study to Assess Adverse Events and Change in Disease Activity of Oral ABBV-453 Alone or in Combination With Multiple Myeloma | Phase 1 / Phase 2 | 2025-07-23 |
| Active Not Recruiting | A Study to Assess Non-Invasive Subcutaneous Fat Reduction in the Submental, Inner Thigh and Back/Bra Areas Wit Non-Surgical Fat Reduction | Phase 4 | 2025-07-22 |
| Completed | Cross-sectional Study to Characterize Real World Burden of Disease in Patients With Vitiligo in China Non-Segmental Vitiligo | — | 2025-07-17 |
| Active Not Recruiting | A Study to Assess Adverse Events and How Oral ABBV-932 Moves Through the Body When Given With Oral Itraconazol Healthy Volunteer | Phase 1 | 2025-07-15 |
| Recruiting | A Study to Assess the Effectiveness of Second-Line Therapy of Upadacitinib and Risankizumab in Adult Participa Crohn's Disease | — | 2025-07-14 |
| Recruiting | A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myel Multiple Myeloma | Phase 1 / Phase 2 | 2025-06-30 |
| Recruiting | A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis Rheumatoid Arthritis | Phase 2 | 2025-06-20 |
| Recruiting | A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants Alopecia Areata | Phase 3 | 2025-06-19 |
| Recruiting | A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Coli Ulcerative Colitis | Phase 3 | 2025-06-17 |
| Completed | A Study to Assess the Relative Bioavailability of Risankizumab Following Subcutaneous Administrations With a P Healthy Volunteers | Phase 1 | 2025-06-12 |
| Recruiting | A Study to Assess Adverse Events and Effectiveness of IntraVenous Infusions of ABBV-CLS-628 in Adult Participa Autosomal Dominant Polycystic Kidney Disease | Phase 2 | 2025-06-09 |
| Recruiting | Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants With Adv Parkinson Disease | — | 2025-06-04 |
| Recruiting | A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanc Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, Fallopian Tube Cancers | Phase 2 | 2025-05-28 |
| Active Not Recruiting | A Study to Assess Safety and Effectiveness of HArmonyCa Lidocaine Injectable Gel for Restoration and/or Creati Mid Face Volume Deficit | Phase 3 | 2025-05-26 |
| Completed | A Study to Assess the Bioavailability of Risankizumab Following Subcutaneous Administration With Prefilled Pen Healthy Volunteers | Phase 1 | 2025-05-08 |
| Recruiting | Study to Assess Real Life Effectiveness of Foslevodopa/Foscarbidopa in Adult German Participants at Initial St Parkinson's Disease | — | 2025-05-06 |
| Recruiting | Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Th Generalized Anxiety Disorder (GAD) | Phase 2 | 2025-04-29 |
| Recruiting | A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combin Metastatic Colorectal Cancer | Phase 2 | 2025-04-24 |
| Completed | A Study to Assess the Relative Bioavailability of Risankizumab Following Subcutaneous Administration With On-B Healthy Volunteer | Phase 1 | 2025-04-21 |
| Recruiting | A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adul Hepatocellular Cancer, Squamous-Cell Non-Small Cell Lung Cancer | Phase 1 | 2025-04-14 |
| Recruiting | Study on Practical ExperienceS of Treatment With Foslevodopa/foScaRbidopa in Advanced Parkinson's Disease Parkinson's Disease | — | 2025-04-14 |
| Recruiting | Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis Psoriatic Arthritis | Phase 2 | 2025-04-11 |
| Recruiting | An Observational Study to Evaluate Effectiveness and Safety of Upadacitinib in Chinese Adult Participants With Ulcerative Colitis | — | 2025-04-09 |
| Active Not Recruiting | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Single Ascending Subcuta Healthy Volunteer | Phase 1 | 2025-04-03 |
| Recruiting | Real-World Study to Assess Subcutaneous Epcoritamab in Adult Participants With Diffuse Large B-Cell and Follic Diffuse Large B-cell Lymphoma, Follicular Lymphoma | — | 2025-03-28 |
| Completed | A Study to Assess the Relative Bioavailability of Oral Tavapadon in Healthy Adult Participants Healthy Volunteer | Phase 1 | 2025-03-26 |
| Completed | A Study to Assess How Food Affects the Movement of Oral ABBV-101 Through the Body of Healthy Adult Participant Healthy Volunteer | Phase 1 | 2025-03-25 |
| Recruiting | Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With Non Small Cell Lung Carcinoma | Phase 1 / Phase 2 | 2025-03-06 |
| Recruiting | Study to Assess Change in Disease Activity of Risankizumab Treatment in Adult Participants With Moderate to Se Ulcerative Colitis | — | 2025-02-27 |
| Active Not Recruiting | A Study to Assess the Relative Bioavailability of Oral ABBV-932 in Healthy Adult Participants Healthy Volunteer | Phase 1 | 2025-02-26 |
| Completed | A Study to Assess the Adverse Events of Intramuscular Injections of AGN-151586 and OnabotulinumtoxinA in Adult Glabellar Lines | Phase 1 | 2025-02-18 |
| Recruiting | A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine Chronic Migraine | Phase 3 | 2025-02-13 |
| Active Not Recruiting | Study to Assess Function and Satisfaction of Oral Ubrogepant in Adult Participants After Multiple Migraine Att Migraine | — | 2025-02-12 |
| Recruiting | A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab E Primary Open Angle Glaucoma | Phase 3 | 2025-02-11 |
| Recruiting | Study of Oral Atogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Men Menstrual Migraine (MM) | Phase 3 | 2025-02-10 |
| Recruiting | An Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psoriatic Arthriti Psoriatic Arthritis | — | 2025-01-31 |
| Active Not Recruiting | A Study Assessing Adverse Event and How Oral ABBV-453 Moves Through the Body in Adult Participants With Relaps Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Phase 1 | 2025-01-27 |
| Active Not Recruiting | A Study to Assess Adverse Events and Effectiveness of OnabotulinumtoxinA Intramuscular Injections for the Chan Forehead Lines | Phase 3 | 2025-01-22 |
| Active Not Recruiting | A Study to Assess the Adverse Events and How Subcutaneous (SC) Injections and Intravenous (IV) Infusions of AB Healthy Volunteer | Phase 1 | 2025-01-22 |
| Active Not Recruiting | Study to Evaluate Adverse Events and Change in Disease Activity When Intravenously (IV) Infused Livmoniplimab Urothelial Carcinoma | Phase 2 | 2025-01-20 |
| Recruiting | A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Thr Non-Small Cell Lung Cancer | Phase 2 | 2025-01-20 |
| Recruiting | Study to Evaluate Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-291 Moves Thr Non-Hodgkin's Lymphoma | Phase 1 | 2025-01-16 |
| Completed | A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of Facial Contouring | Phase 4 | 2025-01-16 |
| Active Not Recruiting | Safety and Efficacy of Upadacitinib in Combination With Topical Corticosteroids in Children From 2 to Less Tha Atopic Dermatitis | Phase 3 | 2024-12-22 |
| Active Not Recruiting | A Study to Evaluate the Effectiveness and Safety of Treatments, Either Alone or in Combination, for the Treatm Atopic Dermatitis | Phase 2 | 2024-12-19 |
| Completed | A Study to Evaluate the Bioavailability and Food Effects of Oral Venetoclax New Tablet Formulation 2.0 in Heal Healthy Volunteer | Phase 1 | 2024-12-19 |
| Recruiting | A Study to Evaluate Safety and Effectiveness of NOA VOLUME Injectable Gel in Adult Participants Compared to JU Mid Face Volume Deficit | Phase 3 | 2024-12-16 |
| Recruiting | A Study to Evaluate the Adverse Events, Efficacy, and Optimal Dose of Intravenous (IV) ABBV-400 in Combination Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Esophageal Adenocarcinoma | Phase 2 | 2024-12-13 |
| Withdrawn | A Study to Assess the Relative Bioavailability of Three Immediate-Release Tablet Formulations of ABBV-903 in H Healthy Volunteers | Phase 1 | 2024-12-01 |
| Completed | A Single Dose Study to Assess Adverse Events and How Oral Icalcaprant Moves Through the Body in Healthy Adult Healthy Volunteer | Phase 1 | 2024-11-26 |
| Recruiting | Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With Migraine Migraine | — | 2024-11-26 |
| Active Not Recruiting | A Real-world Study to Assess Safety of OZURDEX® (Dexamethasone Intravitreal Implant) in Adult Participants Wit Diabetic Macular Edema | — | 2024-11-13 |
| Completed | A Study to Assess Change in How Oral Icalcaprant With Itraconazole Moves Through the Body in Healthy Adult Par Healthy Volunteer | Phase 1 | 2024-11-13 |
| Active Not Recruiting | Study To Assess Effectiveness and Adverse Events of Foscarbidopa/ Foslevodopa in Adult Participants With Advan Advanced Parkinson Disease | — | 2024-11-12 |
| Completed | A Study to Assess the Safety, Tolerability, and Interactions of ABBV-CLS-616 Oral Tablets in Healthy Adult Par Healthy Volunteer | Phase 1 | 2024-11-11 |
| Recruiting | A Study Assessing Adverse Events and Disease Activity When Comparing Intravenously (IV) Infused ABBV-400 to Tr Metastatic Colorectal Cancer | Phase 3 | 2024-11-08 |
| Recruiting | A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world SettING Moderate to Severe Rheumatoid Arthritis | — | 2024-11-07 |
| Recruiting | Evaluation of the Safety and Effectiveness of ARTIA Reconstructive Tissue Matrix Breast Reconstruction (ADORA) Breast Reconstruction | Phase 3 | 2024-11-05 |
| Recruiting | A Study to Assess How the Drug Moves Through the Body, Adverse Events, and Tolerability of Oral ABBV-722 Capsu Healthy Volunteer | Phase 1 | 2024-10-29 |
| Terminated | A Study to Assess Adverse Events of Fosigotifator (ABBV-CLS-7262) in Adults With Major Depressive Disorder Major Depressive Disorder (MDD) | Phase 1 | 2024-10-23 |
| Completed | Study of Oral ABBV-932 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Bipo Bipolar I Disorder, Bipolar II Disorder | Phase 2 | 2024-10-15 |
| Completed | A Study to Evaluate Adverse Events and How the Drug Moves Through the Body From Subcutaneous (SC) and Intraven Healthy Volunteer | Phase 1 | 2024-10-08 |
| Recruiting | A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Epis Migraine | Phase 2 | 2024-10-07 |
| Recruiting | Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Adizutecan (ABBV-400) Moves Th Colorectal Cancer | Phase 1 / Phase 2 | 2024-09-30 |
| Recruiting | Study to Assess Treatment Patterns and Outcomes With Upadacitinib in Adult Participants With Inflammatory Bowe Ulcerative Colitis, Crohn's Disease | — | 2024-09-27 |
| Recruiting | Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for Chronic Migraine, Episodic Migraine, Migraine | — | 2024-09-24 |
| Recruiting | A Study to Assess the Adverse Events and How Intravenously Infused Livmoniplimab in Combination With Budigalim Hepatocellular Carcinoma (HCC) | Phase 1 | 2024-09-11 |
| Completed | A Study to Assess the Relative Bioavailability of Two Formulations of Risankizumab Following Subcutaneous Admi Healthy Volunteers | Phase 1 | 2024-09-11 |
| Recruiting | Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Me Migraine | Phase 3 | 2024-09-10 |
| Terminated | A Study to Assess Multiple Ascending Dose, Drug-Drug Interaction, and Asian Pharmacokinetic Study of ABBV-1088 Healthy Volunteer | Phase 1 | 2024-09-04 |
| Recruiting | Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease Crohn's Disease | Phase 2 | 2024-09-04 |
| Completed | Study of Oral ABBV-932 Capsules to Evaluate Dopamine D2 and D3 Receptor Occupancy in Brain in Adult Healthy Vo Healthy Volunteers | Phase 1 | 2024-08-21 |
| Recruiting | A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Du Atopic Dermatitis | Phase 3 | 2024-08-19 |
| Recruiting | A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or Hidradenitis Suppurativa, Atopic Dermatitis | Phase 2 | 2024-08-14 |
| Recruiting | Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately Crohn's Disease | Phase 3 | 2024-08-08 |
| Completed | A Study to Assess Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization in Chinese Partic Atopic Dermatitis (AD) | — | 2024-08-06 |
| Recruiting | A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Chronic Lymphocytic Leukemia | Phase 3 | 2024-08-05 |
| Recruiting | A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Partic Recurrent Ovarian Cancer, Folate Receptor-Alpha Positive | Phase 2 | 2024-07-29 |
| Completed | A Study to Assess Pharmacokinetic Exposures Following Intravenous and Subcutaneous Administration of Risankizu Healthy Volunteers | Phase 1 | 2024-07-23 |
| Completed | A Study to Assess Adverse Events and Effectiveness of Intradermally Injected JUVÉDERM® VOLITE™ Gel Filler in A Skin Quality Deficit | Phase 2 / Phase 3 | 2024-07-18 |
| Completed | A Study to Assess Relative Bioavailability and Food Effect of ABBV-668 Extended-Release Formulations in Adult Healthy Volunteers | Phase 1 | 2024-07-09 |
| Recruiting | A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Child Juvenile Psoriatic Arthritis | Phase 3 | 2024-07-08 |
| Recruiting | A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderat Hidradenitis Suppurativa | Phase 3 | 2024-06-27 |
| Completed | Study of Oral Upadacitinib to Assess Change in Disease Activity and Adverse Events in Adult Participants With Ulcerative Colitis, Crohn's Disease | — | 2024-06-24 |
| Completed | A Study in Healthy Adult Participants to Assess the Pharmacokinetics, Immunogenicity, Safety, and Tolerability Healthy Volunteers | Phase 1 | 2024-06-24 |
| Completed | An Observational Study to Assess Next Generation Emulsion Preservative Free Eye Drops (NGE-UD) on Dry Eye Symp Dry Eye | — | 2024-06-17 |
| Active Not Recruiting | Study of ABBV-383 Assessing Adverse Events and Clinical Activity With Subcutaneous (SC) Injection in Adult Par Multiple Myeloma | Phase 1 | 2024-06-17 |
| Completed | An Observational Study to Assess Optive MEGA-3 (OM3) on Dry Eye Symptoms and Quality of Life of Adult Particip Dry Eye | — | 2024-06-17 |
| Recruiting | A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Respons Atopic Dermatitis | Phase 3 | 2024-06-14 |
| Recruiting | An Observational Study to Assess Real-World Use of Upadacitinib Tablets in Adolescent and Adult Participants W Atopic Dermatitis | — | 2024-06-07 |
| Withdrawn | Study of Intravenous Telisotuzumab Vedotin in Combination Osimertinib or Standard of Care Chemotherapy to Asse Non-Small Cell Lung Cancer | Phase 3 | 2024-05-31 |
| Withdrawn | A Study to Assess the Effect of Upadacitinib in Atopic Dermatitis-induced Sleep Disturbance in Adults With Mod Atopic Dermatitis, Sleep Disturbance | Phase 3 | 2024-05-23 |
| Recruiting | Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adul Multiple Myeloma | Phase 3 | 2024-05-19 |
| Completed | A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABBV-1088 Oral Dose in Healthy Adult Parti Healthy Volunteers | Phase 1 | 2024-05-13 |
| Completed | A Study to Learn How Safe and Effective Risankizumab is When Compared to Deucravacitinib to Treat Participants Moderate Plaque Psoriasis | Phase 4 | 2024-05-10 |
| Completed | A Phase 1 Trial to Assess Safety, Tolerability and Pharmacokinetics of ALIA-1758 in Healthy Participants Alzheimer Disease | Phase 1 | 2024-05-09 |
| Withdrawn | A Study to Evaluate Adverse Events and Effectiveness of OnabotulinumtoxinA in Participants Undergoing Open Abd Ventral Hernia, Abdominal Hernia | Phase 2 | 2024-05-07 |
| Completed | A Study to Assess BOTOX Injections for the Change of Masseter Muscle Prominence in Adult Participants Masseter Muscle Prominence | Phase 3 | 2024-04-30 |
| Active Not Recruiting | Study to Evaluate the Effectiveness of Risankizumab in Participants With a Recent Diagnosis of Moderate Plaque Moderate Plaque Psoriasis, Moderate Psoriasis, Psoriasis | — | 2024-04-29 |
| Recruiting | A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Hypothyroidism | Phase 2 / Phase 3 | 2024-04-26 |
| Completed | A Study to Assess the Concentrations of Risankizumab in the Breast Milk of Adult Lactating Women With Inflamma Inflammatory Bowel Disease | Phase 4 | 2024-04-24 |
| Completed | A Study to Assess BOTOX Injections in Adult Participants for the Change of Masseter Muscle Prominence Masseter Muscle Prominence | Phase 3 | 2024-04-22 |
| Completed | Observational Study of Oral Cariprazine Capsules to Assess Change in Disease Activity in Adult Participants Wi Bipolar I Disorder | — | 2024-04-18 |
| Recruiting | Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combinat Non-Small Cell Lung Cancer | Phase 2 / Phase 3 | 2024-04-10 |
| Recruiting | A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobuli Immunoglobulin Light Chain (AL) Amyloidosis | Phase 1 / Phase 2 | 2024-04-01 |
| Completed | A Study to Evaluate AGN-151586 Intramuscular Injections in Adult Participants for Treatment of Glabellar Lines Glabellar Lines | Phase 3 | 2024-03-29 |
| Recruiting | Study of Oral Atogepant Tablets to Assess Safety and Efficacy in Adult Participants With Migraine Migraine | Phase 3 | 2024-03-25 |
| Active Not Recruiting | A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lu Ulcerative Colitis | Phase 2 | 2024-03-23 |
| Recruiting | A Study to Assess Adverse Events, and How Intravenously (IV) Infused ABBV-969 Moves Through the Bodies of Adul Metastatic Castration-Resistant Prostate Cancer | Phase 1 | 2024-03-08 |
| Active Not Recruiting | A Study to Asses Effectiveness and Treatment Management of Oral Venetoclax Tablets + Subcutaneously Injected A Acute Myeloid Leukemia | — | 2024-03-04 |
| Completed | A Study to Assess the Mass Balance of [14C] ABBV-552 in Healthy Male Participants Following Single Oral Dose A Healthy Volunteer | Phase 1 | 2024-02-21 |
| Active Not Recruiting | Study to Assess Speed of Onset and Durability of Effectiveness of Upadacitinib in Adult Participants With Mode Crohn's Disease | — | 2024-02-19 |
| Terminated | A Study to Assess the Safety, Pharmacokinetics, and Efficacy of Intravenous (IV) ABBV-303, as Monotherapy and Solid Tumors | Phase 1 | 2024-02-06 |
| Completed | A Study to Evaluate Participant Satisfaction and Natural Outcomes Following Administration of BOTOX Cosmetic I Upper Facial Lines | Phase 4 | 2024-02-05 |
| Completed | A Study to Evaluate Adverse Events and How Single Ascending Doses of ABBV-141 Move Through the Body of Healthy Healthy Volunteers | Phase 1 | 2024-01-29 |
| Recruiting | Real-World Study of ABBV-951 Subcutaneous Infusion to Assess Change in Disease Activity in Adult Participants Parkinson's Disease (PD) | — | 2024-01-24 |
| Terminated | Study of Intramuscular Injections of ABBV-950 to Assess Adverse Events and Change in Disease Activity in Adult Upper Limb Spasticity | Phase 1 | 2024-01-12 |
| Recruiting | A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous Hepatocellular Carcinoma | Phase 2 / Phase 3 | 2024-01-11 |
| Completed | Study of AGN-151586 in Japanese Participants With Moderate to Severe Glabellar Lines Moderate to Severe Glabellar Lines | Phase 1 | 2024-01-05 |
| Withdrawn | A Study to Evaluate Changes in Hair in Adult Participants Taking Oral Oriahnn Capsules With Heavy Menstrual Bl Uterine Fibroids (UF) | — | 2023-12-20 |
| Active Not Recruiting | A Study To Assess Adverse Events and Effectiveness of Upadacitinib Oral Tablets in Adult and Adolescent Partic Vitiligo | Phase 3 | 2023-12-19 |
| Completed | A Study to Evaluate the Safety and Effectiveness of ELAPR002f Injectable Gel for the Improvement of Skin Quali Skin Quality Deficit | Phase 2 | 2023-12-19 |
| Completed | A Study to Assess the Adverse Events and Effectiveness of BOTOX Injections for the Treatment of Moderate to Se Forehead Lines | Phase 3 | 2023-12-12 |
| Recruiting | A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizuma Crohn's Disease | Phase 3 | 2023-12-11 |
| Recruiting | A Study to Evaluate Adverse Events and Change in Disease Activity With the XEN45 Glaucoma Treatment System Imp Open-angle Glaucoma, OAG | Phase 4 | 2023-12-08 |
| Completed | Study to Assess Accuracy of Rapid Mood Screener in Adult Participants With Unipolar Major Depressive Disorder Bipolar I Disorder | — | 2023-12-04 |
| Recruiting | An Observational Study of Subcutaneous Infusion of ABBV-951 to Assess Change in Disease Activity and Adverse E Parkinson's Disease (PD) | — | 2023-11-30 |
| Recruiting | A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Receiving Or Acute Myeloid Leukemia | — | 2023-11-30 |
| Completed | A Two-Part First-In-Human Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of G Healthy Volunteers, Overweight | Phase 1 | 2023-11-29 |
| Completed | A Study to Assess Adverse Events and Change of Masseter Muscle Prominence Using BOTOX Injections in Adult Part Masseter Muscle Prominence | Phase 3 | 2023-11-22 |
| Active Not Recruiting | ELAPR002f Injectable Gel in the Treatment of Atrophic Acne Scars Atrophic Acne Scars | Phase 3 | 2023-11-21 |
| Completed | A Study to Compare the Bioavailability of Intravenously Infused Risankizumab Manufactured by Two Different Pro Healthy Volunteers | Phase 1 | 2023-11-20 |
| Active Not Recruiting | A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatme Crohn's Disease | Phase 3 | 2023-11-15 |
| Terminated | Study to Evaluate Adverse Events and Movement of Intravenously (IV) Infused ABBV-787 in Adult Participants Wit Acute Myeloid Leukemia | Phase 1 | 2023-11-13 |
| Active Not Recruiting | Study to Assess Adverse Events and Change in Disease Activity in Previously Treated Adult Participants Receivi Unresectable Metastatic Colorectal Cancer | Phase 2 | 2023-11-12 |
| Completed | An Observational Study to Validate the Cumulative Life Course Impairment (CLCI) Instrument (DermCLCI-p) in Adu Psoriasis | — | 2023-11-09 |
| Active Not Recruiting | Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Hepatocellular Carcinoma, Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancers | Phase 1 | 2023-11-09 |
| Recruiting | A Study to Assess Change in Functioning and Health Related Quality of Life in Adult Participants With Chronic Chronic Lymphocytic Leukemia | — | 2023-11-06 |
| Active Not Recruiting | Study to Assess Adverse Events, Change in Disease Activity, and How Oral Upadacitinib Moves Through the Body o Ulcerative Colitis | Phase 3 | 2023-11-06 |
| Completed | A Study to Assess Prevalence of a Specific Protein Overexpression in Adult Participants With Non-Small Cell Lu Non Small Cell Lung Cancer | — | 2023-11-03 |
| Active Not Recruiting | Observational Study of Adult Participants With Diabetic Macular Edema and Suboptimal Response to Anti-Vascular Diabetic Macular Edema | — | 2023-10-30 |
| Completed | An Observational Study to Assess Participant-Reported Real-World Experience of Risankizumab On-body Injector ( Crohn's Disease | — | 2023-10-26 |
| Completed | A Study to Assess the Effectiveness of BOTOX (Botulinum Toxin Type A) Injections for the Change of Masseter Mu Masseter Muscle Prominence | Phase 3 | 2023-10-17 |
| Terminated | A Study to Assess Change in Disease Activity, Adverse Events, and How the Drug Moves Through the Body in Adult Human Immuno-deficiency Virus (HIV) Disease | Phase 2 | 2023-10-12 |
| Recruiting | A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants Alopecia Areata | Phase 3 | 2023-10-11 |
| Active Not Recruiting | Comparative Study of Oral Atogepant Versus Oral Topiramate to Assess Adverse Events in Adult Participants With Migraine | Phase 3 | 2023-10-07 |
| Withdrawn | A Study to Assess Food Effect of Venetoclax New Tablet Formulation in Healthy Female Participants Healthy Volunteers | Phase 1 | 2023-10-05 |
| Recruiting | Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Ad Juvenile Idiopathic Arthritis | Phase 3 | 2023-10-02 |
| Completed | Relative Bioavailability of Two Lutikizumab Formulations and Pharmacokinetics, Safety, and Tolerability of Lut Healthy Volunteers | Phase 1 | 2023-09-28 |
| Active Not Recruiting | Study to Evaluate Adverse Events, and Change in Disease Activity, When Intravenously (IV) Infused With Livmoni Hepatocellular Carcinoma | Phase 2 | 2023-09-21 |
| Completed | Study of Intramuscular Injections of OnabotulinumtoxinA to Assess Change in Disease Activity in Pediatric Part Spasticity | — | 2023-09-08 |
| Completed | A Study to Assess Adverse Events and Effectiveness of HAC 20L Injections in Adult Participants for the Treatme Nasolabial Folds | Phase 2 / Phase 3 | 2023-09-05 |
| Completed | A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of ABBV-932 in Healthy Adult Participants, Healthy Volunteers, Generalized Anxiety Disorder (GAD), Bipolar Disorder (BPD) | Phase 1 | 2023-08-31 |
| Terminated | A Study to Assess Pharmacokinetics, Safety, and Tolerability of ABBV-903 in Healthy Japanese and Han Chinese P Healthy Volunteers | Phase 1 | 2023-08-23 |
| Completed | A Study to Assess the Mass Balance of [14C] ABBV-903 in Healthy Male Participants Following Single Oral Dose A Healthy Volunteer | Phase 1 | 2023-08-18 |
| Active Not Recruiting | Real World Study of Oral Upadacitinib Tablets to Assess Adverse Events and Change in Disease Activity in Adole Atopic Dermatitis (AD) | — | 2023-08-18 |
| Completed | Study to Assess the Safety and Efficacy of Subcutaneously Injected Risankizumab in Adult Participants With Gen Genital Psoriasis, Scalp Psoriasis | Phase 4 | 2023-08-10 |
| Completed | A Study to Evaluate Efficacy, Safety, and Tolerability of Darigabat in Participants With Panic Disorder Panic Disorder | Phase 2 | 2023-07-31 |
| Recruiting | An Observational Study to Assess Change in Disease Activity and Adverse Events in Adolescent and Adult Partici Crohn's Disease | — | 2023-07-28 |
| Completed | A Study to Evaluate Pharmacokinetic and Safety Trial of Emraclidine in Participants With Renal Impairment Comp Renal Impairment | Phase 1 | 2023-07-24 |
| Recruiting | Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants Wit Systemic Lupus Erythematosus | Phase 3 | 2023-07-19 |
| Completed | Study of Oral Atogepant Tablets to Assess Change in Disease Activity in Adult Japanese Participants With Episo Migraine | Phase 3 | 2023-07-12 |
| Completed | Study to Assess Adverse Events and Compare How Oral Ubrogepant and Oral Atogepant Moves Through the Body of He Healthy Volunteers | Phase 1 | 2023-07-11 |
| Completed | A Study to Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics of Emraclidine Hepatic Impairment | Phase 1 | 2023-06-30 |
| Completed | A Study to Assess Symptom Relief and Product Tolerability of ABBV-444 Drops in Adult Participants Dry Eye Syndrome | Phase 3 | 2023-06-27 |
| Completed | An Observational Study to Assess Ubrogepant Tablets and Atogepant Tablets to Treat Migraine in Adult Participa Migraine | — | 2023-06-25 |
| Completed | A Study to Assess Drug-Drug Interaction Between ABBV-903 and Midazolam in Adult Healthy Volunteers Healthy Volunteer | Phase 1 | 2023-06-23 |
| Recruiting | A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent P Hidradenitis Suppurativa | Phase 3 | 2023-06-21 |
| Active Not Recruiting | Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Ad Rheumatoid Arthritis | Phase 3 | 2023-06-15 |
| Completed | Study to Assess Adverse Events and Compare How Crushed, Ground, and Intact Oral Tablets Venetoclax Moves Throu Healthy Volunteers | Phase 1 | 2023-06-15 |
| Completed | A Study to Assess Adverse Events and Effectiveness of HAC 22L Injection for Mid-Face Volume in Adult Participa Facial Volume Deficit | Phase 3 | 2023-06-14 |
| Active Not Recruiting | An Observational Study to Assess Change in Disease Activity and Adverse Events In Adult Participants With Mode Crohn's Disease | — | 2023-06-09 |
| Active Not Recruiting | Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Hematologic Cancer | Phase 1 | 2023-06-09 |
| Completed | A Study to Assess Frequency of Undetectable Minimal Residual Disease (uMRD) in Adult Participants With Chronic Chronic Lymphocytic Leukemia | — | 2023-06-07 |
| Completed | Study to Assess Adverse Events, Change in Disease Activity and How Oral ABBV-552 Capsules Moves Through the Bo Alzheimer's Disease (AD) | Phase 2 | 2023-06-05 |
| Enrolling By Invitation | Long-term Extension Study to Assess Adverse Events of Oral Atogepant Tablets in Pediatric Participants (6 to 1 Migraine Prophylaxis | Phase 3 | 2023-06-05 |
| Withdrawn | A Study to Explore Treatment Patterns, Treatment Outcomes, Healthcare Resource Utilization in Adult Participan Acute Myeloid Leukemia | — | 2023-06-01 |
| Completed | A Study to Assess Treat-to-Target and Dosing Flexibility of Oral Upadacitinib Tablets in Adult Participants Wi Atopic Dermatitis | Phase 4 | 2023-05-29 |
| Recruiting | A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Par Episodic Migraine | Phase 3 | 2023-05-01 |
| Completed | A Study to Assess Adverse Events and Change in Disease Activity in Pediatric Participants (Age 6 Months to <2 Functional Constipation | Phase 2 | 2023-04-27 |
| Recruiting | A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Diffuse Large B-Cell Lymphoma, Chronic Lymphocytic Leukemia, Follicular Lymphoma | Phase 1 | 2023-04-26 |
| Terminated | Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Moderate to Severe Ulcerative Colitis Ulcerative Colitis | Phase 2 | 2023-04-24 |
| Completed | A Study to Assess the Relative Bioavailability of Immediate Release Formulations of ABBV-903 in Healthy Adult Healthy Volunteer | Phase 1 | 2023-04-18 |
| Completed | A Study to Assess Adverse Events and Effectiveness of Injected JUVÉDERM® VOLITE™ Gel Filler for Change in Neck Neck Lines | Phase 3 | 2023-04-07 |
| Recruiting | Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Diffuse Large B-Cell Lymphoma, Chronic Lymphocytic Leukemia, B Cell Malignancies | Phase 1 | 2023-04-04 |
| Recruiting | A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Multiple Myeloma | Phase 1 | 2023-03-21 |
| Completed | Study of ABBV-668 Oral Capsules to Assess Adverse Events and Change in Disease Activity in Adult Participants Ulcerative Colitis | Phase 2 | 2023-03-16 |
| Recruiting | Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer | Phase 3 | 2023-03-15 |
| Active Not Recruiting | An Observational Study to Assess Change in Disease Activity and Use of Upadacitinib Tablets in Adolescent and Atopic Dermatitis | — | 2023-02-21 |
| Completed | Study to Assess Adverse Events and How ABBV-932 Oral Capsules Moves Through the Body of Healthy Adult Particip Generalized Anxiety Disorder (GAD), Healthy Participants | Phase 1 | 2023-02-15 |
| Completed | Effect of Long-term Psoriasis on Patients' Life - CORONATE Psoriasis | — | 2023-01-26 |
| Completed | A Study to Assess the Adverse Events and How Oral ABBV-552 Capsules Moves Through the Body of Healthy Adult Ja Healthy Volunteers | Phase 1 | 2023-01-17 |
| Active Not Recruiting | First in Human Study of IMGN151 in Recurrent Gynaecological Cancers Endometrial Cancer, High Grade Serous Adenocarcinoma of Ovary, Primary Peritoneal Carcinoma | Phase 1 | 2023-01-11 |
| Recruiting | Observational Study to Assess Adverse Events When Adult Female Participants Are Treated With Ubrelvy (Ubrogepa Migraine | — | 2023-01-10 |
| Completed | A Study to Evaluate Satisfaction in Adult Participants With the Aesthetics of the Periorbital Area After JUVÉD Facial Corrections, Facial Lines | Phase 4 | 2023-01-05 |
| Completed | A Study to Assess Adverse Events and How Single and Multiple Ascending Doses of ABBV-903 Move Through the Body Healthy Volunteer | Phase 1 | 2023-01-03 |
| Completed | A Study to Assess Adverse Events and Change in Symptoms With Linaclotide Versus Placebo in Pediatric Subjects, Functional Constipation (FC), Chronic Idiopathic Constipation (CIC) | Phase 3 | 2022-12-29 |
| Completed | An Observational Study to Assess Change in Disease Activity and Adverse Events of Rinvoq in Adult Participants Ulcerative Colitis | — | 2022-12-19 |
| Completed | An Observational Study to Assess Change in Disease Activity When Ubrogepant Tablets Are Combined With Atogepan Migraine | — | 2022-12-18 |
| Active Not Recruiting | An Observational Study to Assess Change in Disease Activity and Treatment Patterns of Upadacitinib When Given Psoriatic Arthritis | — | 2022-12-15 |
| Completed | A Study to Assess Change in Patient Experience in Adult Participants With Chronic Lymphocytic Leukemia (CLL) R Chronic Lymphocytic Leukemia | — | 2022-12-14 |
| Completed | A Study to Assess Change in Disease Activity in Adolescents and Adults With Moderate to Severe Prurigo-type At Atopic Dermatitis | — | 2022-12-08 |
| Active Not Recruiting | Study to Evaluate Adverse Events, Change in Disease Activity, and How ABBV-706 Moves Through the Body When Int Advanced Solid Tumors | Phase 1 | 2022-12-05 |
| Completed | A Multiple Dose Trial of Emraclidine in Elderly Participants and in Participants With Dementia Due to Alzheime Healthy Participants, Alzheimer's Disease Dementia | Phase 1 | 2022-12-02 |
| Completed | A Study to Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Atopic Dermatitis | Phase 3 | 2022-11-28 |
| Terminated | A Study to Assess Disease Activity of Intravenously (IV) Infused Telisotuzumab Vedotin in Adult Participants W Non Small Cell Lung Cancer | Phase 2 | 2022-11-21 |
| Completed | An Observational Study to Assess Change in Disease Activity and Adverse Events of Adalimumab in Chinese Pediat Polyarticular Juvenile Idiopathic Arthritis | — | 2022-11-10 |
| Recruiting | Study of Oral Upadacitinib to Assess Change in Disease Activity in Adult Participants With Ulcerative Colitis Ulcerative Colitis | — | 2022-10-20 |
| Active Not Recruiting | A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused Etentamig (ABBV- Relapsed/Refractory Multiple Myeloma | Phase 1 | 2022-10-20 |
| Completed | Study to Assess Adverse Events and Compare How Two Subcutaneous ABBV-154 Injection Formulations Move Through t ABBV-154 | Phase 1 | 2022-10-18 |
| Completed | Study to Evaluate the Relative Bioavailability of Two Risankizumab Drug Product Presentations in Healthy Volun Healthy Volunteers | Phase 1 | 2022-09-28 |
| Active Not Recruiting | Mirvetuximab Soravtansine (MIRV) With Carboplatin in Second-line Treatment of Folate Receptor Alpha (FRα) Expr High Grade Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer | Phase 2 | 2022-09-28 |
| Completed | A Study to Assess How Food Affects the Safety and Pharmacokinetics of Galicaftor and Navocaftor Healthy Volunteers | Phase 1 | 2022-09-27 |
| Completed | A Study to Assess the Pharmacokinetics and Safety of Co-administered Oral Galicaftor, Navocaftor, and ABBV-576 Healthy Volunteers | Phase 1 | 2022-09-20 |
| Completed | A Study to Assess Adverse Events and Effectiveness of Intradermally Injected JUVÉDERM® VOLITE™ Gel Filler in A Perioral Lines | Phase 3 | 2022-09-07 |
| Active Not Recruiting | A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Ineligible f Acute Myeloid Leukemia | — | 2022-09-07 |
| Completed | A Study to Evaluate Safety and Tolerability of CVL-231 (Emraclidine) in Adult Participants With Schizophrenia Schizophrenia | Phase 2 | 2022-09-02 |
| Completed | A Study to Evaluate Sequential Administration of AGN-151586 and OnabotulinumtoxinA (BOTOX) Injections in Adult Glabellar Lines | Phase 1 | 2022-08-30 |
| Completed | A Study to Explore Treatment Patterns, Treatment Outcomes, Healthcare Resource Utilization in Adult Participan Myelofibrosis | — | 2022-08-23 |
| Terminated | Study to Assess Adverse Events and Change in Disease Activity of Oral Cariprazine Capsules in Adult Participan Schizophrenia | Phase 3 | 2022-08-18 |
| Completed | A Study to Assess Safety of ABBV-916 and How Intravenous ABBV-916 Moves Through Body and Affects Brain Amyloid Alzheimer's Disease (AD) | Phase 2 | 2022-08-15 |
| Active Not Recruiting | An Observational Study to Assess Change in Disease Activity and Adverse Events of Upadacitinib in Adult Partic Ulcerative Colitis | — | 2022-08-15 |
| Terminated | Study to Assess Adverse Events and How Oral ABBV-990 Moves Through the Body of Adult Healthy Participants Healthy Volunteers | Phase 1 | 2022-07-25 |
| Completed | Study to Assess Change in Disease Activity and Adverse Events of Ab Externo Approach for Glaucoma Gel Stent (X Open-Angle Glaucoma | Phase 3 | 2022-07-22 |
| Completed | A Study to Assess Change in Disease Activity and Adverse Events of Adalimumab in Chinese Participants Requirin Non-infectious Intermediate Posterior- or Pan-uveitis | Phase 4 | 2022-07-07 |
| Completed | Study of Cariprazine Oral Capsules or Solution to Assess Adverse Events and Change in Irritability Due to Auti Autism Spectrum Disorder | Phase 3 | 2022-07-07 |
| Completed | Study to Assess Change in Disease Activity and Adverse Events of RINVOQ in Adult Participants With Ankylosing Ankylosing Spondylitis | — | 2022-07-06 |
| Terminated | A Study to Assess Safety of Cedirogant and How Cedirogant Moves Through the Body in Adult Participants With Mi Hepatic Impairment | Phase 1 | 2022-07-06 |
| Completed | A Trial of 15 and 30 mg Doses of CVL-231 (Emraclidine) in Participants With Schizophrenia Schizophrenia | Phase 2 | 2022-07-05 |
| Completed | A Trial of 10 and 30 mg Doses of CVL-231 (Emraclidine) in Participants With Schizophrenia Schizophrenia | Phase 2 | 2022-06-30 |
| Completed | A Study of Subcutaneous HUMIRA (Adalimumab) Injection to Assess Adverse Events and Change in Disease Activity Crohn's Disease | — | 2022-06-29 |
| Completed | An Observational Study of Upadacitinib to Assess Change in Disease Activity in Canadian Adult Participants Wit Atopic Dermatitis | — | 2022-06-01 |
| Recruiting | A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Ineligible f Acute Myeloid Leukemia | — | 2022-05-26 |
| Active Not Recruiting | A Study to Assess the Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Ref Relapsed/Refractory Multiple Myeloma | Phase 1 | 2022-05-17 |
| Completed | A Study to Assess Adverse Events and Change in Disease Activity of JUVÉDERM® VOLITE™ XC Injectable Gel for Cha Neck Lines | Phase 3 | 2022-05-02 |
| Completed | An Observational Study to Assess the Impact of Upadacitinib in Adult Hungarian Participants With Moderate to S Rheumatoid Arthritis | — | 2022-04-20 |
| Completed | Study of BOTOX Injections to Assess Change in Disease Symptoms in Adult Participants With Upper Limb Essential Upper Limb Essential Tremor (UL ET) | Phase 2 | 2022-04-12 |
| Enrolling By Invitation | Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With Diabetic R Diabetic Retinopathy, DR | — | 2022-04-04 |
| Completed | Study of BOTOX Injections to Assess Change in Disease Activity and Adverse Events in Adult Female Participants Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) | Phase 2 | 2022-03-29 |
| Recruiting | Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutu Chronic Lymphocytic Leukemia (CLL) | Phase 2 | 2022-03-28 |
| Recruiting | A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Non Small Cell Lung Cancer | Phase 3 | 2022-03-25 |
| Active Not Recruiting | A Study to Assess Adverse Events and Change in Disease State of Intravenously (IV) Infused Etentamig (ABBV-383 Relapsed/Refractory Multiple Myeloma | Phase 1 | 2022-03-24 |
| Completed | Study of Oral Atogepant When Added to OnabotulinumtoxinA (BOTOX) to Assess Adverse Events and Change in Diseas Chronic Migraine | Phase 3 | 2022-03-22 |
| Completed | A Study to Assess Adverse Events and Change in Disease Activity of Intramuscular AGN-151586 Injection in Adult Glabellar Lines | Phase 3 | 2022-03-16 |
| Completed | An Observational Study to Assess the Real-World Effectiveness of Upadacitinib in Adult Participants With Rheum Rheumatoid Arthritis | — | 2022-03-14 |
| Completed | A Study to Assess Adverse Events and Change in Disease Activity of Intramuscular AGN-151586 Injection in Toxin Glabellar Lines | Phase 3 | 2022-03-08 |
| Completed | Study to Assess Adverse Events When Ubrogepant Tablets in Combination With Atogepant Tablets Are Used to Treat Episodic Migraine | Phase 4 | 2022-03-07 |
| Completed | A Study to Assess Adverse Events of Intramuscular AGN-151586 Injection in Adult Participants With Glabellar Li Glabellar Lines | Phase 3 | 2022-02-25 |
| Terminated | A Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Ag Crohn's Disease | Phase 2 | 2022-01-31 |
| Completed | Study to Assess How ABBV-951 is Absorbed When Administered at Different Subcutaneous Sites of Adult Participan Parkinson's Disease | Phase 1 | 2022-01-18 |
| Terminated | Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Lemzoparlimab With or Withou Multiple Myeloma | Phase 1 | 2022-01-17 |
| Enrolling By Invitation | Long-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment Migraine | Phase 3 | 2022-01-14 |
| Recruiting | Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD AMD, nAMD, Wet Age-related Macular Degeneration | Phase 3 | 2022-01-13 |
| Recruiting | Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migr Migraine | Phase 3 | 2022-01-13 |
| Terminated | A Study to Evaluate Pregnancy Outcomes in Females Treated With Oral Elagolix Tablets and Capsules Endometriosis, Uterine Fibrioids | — | 2022-01-06 |
| Active Not Recruiting | Study to Assess Adverse Events and Change in Disease State of Oral Venetoclax in Combination With Subcutaneous Acute Myeloid Leukemia (AML) | Phase 4 | 2022-01-06 |
| Active Not Recruiting | A Study to Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Hidradenitis Suppurativa | Phase 2 | 2021-12-28 |
| Completed | A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Ineligible f Acute Myeloid Leukemia | — | 2021-12-27 |
| Enrolling By Invitation | Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With nAMD Neovascular Age-Related Macular Degeneration (nAMD), Gene Therapy, AMD | — | 2021-12-20 |
| Active Not Recruiting | A Study to Assess Disease Activity in Adolescent and Adult Participants With Atopic Dermatitis Who Receive Ora Atopic Dermatitis | — | 2021-12-13 |
| Recruiting | A Study to Assess Disease Activity in Adult Participants With Axial Spondyloarthritis Who Receive Upadacitinib Axial Spondylarthritis (r-axSpA) | — | 2021-11-22 |
| Active Not Recruiting | A Study to Assess Real-World Use, Safety, and Effectiveness of Oral Upadacitinib in Adult and Adolescent (>=12 Atopic Dermatitis | — | 2021-11-17 |
| Completed | A Study To Assess the Safety of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants With Platysma Prominence | Phase 3 | 2021-11-16 |
| Terminated | A Study to Assess Adverse Events and Disease Activity With Cedirogant (ABBV-157) in Adult Participants With Mo Psoriasis | Phase 2 | 2021-11-16 |
| Withdrawn | A Study Evaluating the Bioavailability and Food Effect of Veliparib Tablets Followed by an Extension in Subjec Cancer - Ovarian | Phase 1 | 2021-11-15 |
| Completed | Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax in Combination With Intraveno Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) | Phase 2 | 2021-11-08 |
| Terminated | Study of BOTOX Injections in Prevention of Migraine in Adult Participants With Episodic Migraine Episodic Migraine | Phase 3 | 2021-11-05 |
| Recruiting | Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Hea Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Micro Satellite Stable Colorectal Cancer | Phase 1 | 2021-11-01 |
| Completed | Mirvetuximab Soravtansine Monotherapy in Platinum-Sensitive Epithelial, Peritoneal, and Fallopian Tube Cancers Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer | Phase 2 | 2021-10-19 |
| Completed | Study to Evaluate Symptoms of Exocrine Pancreatic Insufficiency in Adult Participants With Cystic Fibrosis or Cystic Fibrosis, Chronic Pancreatitis | Phase 4 | 2021-10-14 |
| Active Not Recruiting | Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Non-Small Cell Lung Cancer, Advanced Solid Tumors, Gastroesophageal Adenocarcinoma | Phase 1 | 2021-10-13 |
| Completed | A Study to Evaluate an Updated Dexamethasone Intravitreal (Into the Eye) Applicator in Adult Participants With Macular Edema | Phase 3 | 2021-10-12 |
| Terminated | A Study to Assess Patient-Reported Quality of Life and Effectiveness on Control of Bleeding in Adult Participa Heavy Menstrual Bleeding, Uterine Fibroids | — | 2021-10-05 |
| Completed | A Study to Evaluate Adverse Events and Change in Disease State of Oral Upadacitinib in Adolescent Participants Atopic Dermatitis | — | 2021-09-29 |
| Terminated | A Phase 1 Study to Investigate the Safety and Pharmacokinetics of Fosigotifator in Patients With Amyotrophic L ALS, Amyotrophic Lateral Sclerosis | Phase 1 | 2021-09-22 |
| Terminated | Study to Evaluate Adverse Events and Change in Disease Activity With Oral Capsules of Galicaftor/Navocaftor/AB Cystic Fibrosis (CF) | Phase 2 | 2021-09-20 |
| Completed | Effect of CREON on Exocrine Pancreatic Insufficiency (EPI) Symptoms Chronic Pancreatitis | — | 2021-09-16 |
| Terminated | A Study to Evaluate the Change in Disease State and Adverse Events in Adult Participants With Polymyalgia Rheu Polymyalgia Rheumatica | Phase 2 | 2021-09-09 |
| Completed | Study to Evaluate Adverse Events and Change in Disease Activity in Adult and Adolescent Participants With Acut Hepatitis C Virus (HCV) | Phase 3 | 2021-08-24 |
| Withdrawn | A Study To Assess Adverse Events and Change in Disease Activity With Oral Cariprazine When Added to Antidepres Generalized Anxiety Disorder | Phase 2 | 2021-08-18 |
| Enrolling By Invitation | A Study Evaluating Oral Eluxadoline Administered to Pediatric Participants With Irritable Bowel Syndrome With Irritable Bowel Syndrome | Phase 3 | 2021-08-13 |
| Completed | A Study To Assess the Safety and Effects of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Partic Platysma Prominence | Phase 3 | 2021-08-10 |
| Recruiting | Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Ex Plaque Psoriasis, Psoriatic Arthritis, Crohn's Disease, or Other Conditions for Which Risankizumab is an FDA-approved Treatment | — | 2021-07-30 |
| Active Not Recruiting | Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 6 and 17 Years With Mo Psoriasis | Phase 3 | 2021-07-24 |
| Completed | Study to Assess Adverse Events and the Movement of Oral Venetoclax Tablet Through the Body of Female Participa Renal Impairment, Renal Disease | Phase 1 | 2021-07-08 |
| Completed | A Study To Assess the Safety and Effects of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Partic Platysma Prominence | Phase 3 | 2021-07-08 |
| Completed | Study to Evaluate t(11;14) Status and BCL2 Expression in Adult Participants With Multiple Myeloma (MM) Multiple Myeloma (MM) | — | 2021-07-07 |
| Completed | Study to Evaluate Adverse Events and Change in Disease Activity With Oral Tablets of Upadacitinib in Adult Par Non-Segmental Vitiligo | Phase 2 | 2021-06-30 |
| Terminated | Study to Evaluate Adverse Events and Movement of Lemzoparlimab in Body When Used Intravenously (IV) With Azaci Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) | Phase 1 | 2021-06-25 |
| Terminated | Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age Rheumatoid Arthritis (RA) | Phase 2 | 2021-06-23 |
| Withdrawn | Study to Assess Adverse Events When Subcutaneous Risankizumab Injection is Given to Adult Participants With Ps Psoriasis | — | 2021-06-23 |
| Terminated | A Trial of the Safety, Tolerability, and Pharmacodynamics of CVL-871 in Subjects With Dementia-Related Apathy Apathy in Dementia | Phase 2 | 2021-06-22 |
| Completed | Study of Subcutaneous Risankizumab Injection Compared to Oral Apremilast Tablets to Assess Change in Disease A Psoriasis | Phase 4 | 2021-06-09 |
| Completed | Study to Assess the Change in Disease State When Subcutaneous Risankizumab Injection is Given to Adult Partici Psoriasis | — | 2021-05-31 |
| Terminated | Study to Evaluate Adverse Events and Change in Disease Activity When Intravenous (IV) Infusion of ABBV-927 is Pancreatic Cancer | Phase 1 | 2021-05-28 |
| Completed | Study of Oral Venetoclax Tablets to Evaluate Adverse Events and Change in Disease Activity in Participants of Acute Myeloid Leukemia (AML) | — | 2021-05-28 |
| Terminated | Study to Assess Adverse Events, Change in Disease Activity and How Oral ABBV-4083 Capsules When Given Alone or Onchocerciasis | Phase 2 | 2021-05-22 |
| Completed | A Study to Assess the Impact and Adverse Events of Topical Eyedrops of AGN-190584 on Night-driving Performance Presbyopia | Phase 3 | 2021-05-14 |
| Completed | A Study of the Change in Early and Sustained Pain Control in Axial Spondylarthritis in Adult Participants Rece Axial Spondylarthritis (axSpA) | — | 2021-04-30 |
| Recruiting | A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Dep Depression, Bipolar I Disorder | Phase 3 | 2021-04-28 |
| Terminated | Study to Evaluate Adverse Events, Change in Disease Activity, Movement of Oral ABBV-623 and ABBV-992 Tablets i B-cell Lymphoma | Phase 1 | 2021-04-27 |
| Active Not Recruiting | Study to Assess Change in Disease Symptoms in Adult Participants With Moderate to Severe Psoriasis Treated Wit Psoriasis | — | 2021-04-26 |
| Completed | Study to Assess Participant/Caregiver/Investigator Satisfaction of Video-Assisted Telenursing in Adult Partici Parkinson's Disease | — | 2021-04-22 |
| Completed | Study to Assess Adverse Events and How Intravenous (IV) or Subcutaneous (SC) ABBV-382 Moves Through the Body o Human Immunodeficiency Virus (HIV) | Phase 1 | 2021-04-16 |
| Completed | Study of Oral Venetoclax Tablets to Evaluate Adverse Events and Change in Disease Activity in Participants Abo Acute Myeloid Leukemia (AML) | — | 2021-04-05 |
| Completed | Study To Assess Adverse Events and Drug to Drug Interaction of Oral Tablet Atogepant and Ubrogepant in Adult P Migraine | Phase 1 | 2021-03-17 |
| Terminated | Safety and Tolerability Study of Mivebresib Tablet Alone or in Combination With Ruxolitinib Tablet or Navitocl Myelofibrosis (MF) | Phase 1 | 2021-03-17 |
| Completed | Study to Evaluate the Safety and How the Body Handles a Single Dose of Subcutaneous (SC) and Intravenous (IV) Human Immunodeficiency Virus (HIV) | Phase 1 | 2021-03-15 |
| Completed | Study of Subcutaneous (Injected Under the Skin) Risankizumab to Assess Change in Disease Symptoms in Adult Par Psoriasis | Phase 3 | 2021-02-26 |
| Completed | Open-label Trial in Parkinson's Disease (PD) Parkinson Disease | Phase 3 | 2021-02-24 |
| Active Not Recruiting | Study of Intravenous (IV) ABBV-637 Alone or in Combination With IV Docetaxel/Osimertinib to Assess Adverse Eve Advanced Solid Tumors Cancer, Non Small Cell Lung Cancer (NSCLC) | Phase 1 | 2021-02-23 |
| Completed | RGX-314 Gene Therapy Pharmacodynamic Study for Neovascular Age-related Macular Degeneration (nAMD) Neovascular Age-related Macular Degeneration, Wet Macular Degeneration, Wet Age-related Macular Degeneration | Phase 2 | 2021-02-22 |
| Completed | A Long-Term Safety and Tolerability Extension Study Evaluating Atogepant for the Prevention of Chronic or Epis Episodic Migraine, Chronic Migraine | Phase 3 | 2021-02-19 |
| Active Not Recruiting | Study To Assess Adverse Events and Change in Disease Activity Of 24-hour Continuous Subcutaneous Infusion Of A Parkinson's Disease (PD) | Phase 3 | 2021-02-18 |
| Completed | A Study to Assess Adverse Events and Change in Disease State in Adult Participants Being Treated With Humira i Pyoderma Gangrenosum | — | 2021-02-12 |
| Completed | A Study to Assess the Change in Disease State in Adult Participants Being Treated With Oral Upadacitinib Table Psoriatic Arthritis | — | 2021-02-04 |
| Completed | Open-Label, Flexible-dose Study to Evaluate the Long-Term Safety and Tolerability of Cariprazine in the Treatm Schizophrenia, Bipolar I Disorder, Autism Spectrum Disorder (ASD) | Phase 3 | 2021-02-01 |
| Completed | A Study of Oral Upadacitinib (RINVOQ) Tablets to Assess Adverse Events and Change in Disease Symptoms in Korea Rheumatoid Arthritis (RA), Atopic Dermatitis (AD), Ankylosing Spondylitis (AS) | — | 2021-01-26 |
| Recruiting | Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One AMD, nAMD, Wet Age-related Macular Degeneration | Phase 2 / Phase 3 | 2020-12-29 |
| Withdrawn | A Study of Oral Upadacitinib Tablets to Assess Change in Disease State in Participants Aged 12-75 Years With M Atopic Dermatitis (AD) | Phase 3 | 2020-12-24 |
| Completed | Study Of Oral Elagolix Tablets To Assess the Tolerability and Change in Disease Symptoms in Adult Female Parti Endometriosis | — | 2020-12-14 |
| Terminated | Study of Oral Venetoclax Tablets in Combination With Intravenous Obinutuzumab Injection to Assess Achievement Chronic Lymphocytic Leukemia (CLL) | — | 2020-12-12 |
| Completed | Study to Assess Adverse Events and How Intravenous (IV) ABBV-47D11 and IV ABBV-2B04 Given Alone and in Combina CoronaVirus Disease-2019 (COVID-19) | Phase 1 | 2020-12-10 |
| Terminated | An Open-label Extension Trial of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures Seizures | Phase 2 | 2020-12-08 |
| Active Not Recruiting | RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Diabetic Retinopathy (DR) Diabetic Retinopathy (DR), Center-Involved Diabetic Macular Edema (CI-DME) | Phase 2 | 2020-11-20 |
| Recruiting | AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension Open-angle Glaucoma, Ocular Hypertension | Phase 1 / Phase 2 | 2020-11-16 |
| Active Not Recruiting | Safety and Tolerability Study of Oral ABBV-744 Tablet Alone or in Combination With Oral Ruxolitinib Tablet or Myelofibrosis (MF) | Phase 1 | 2020-11-11 |
| Completed | A Safety and Efficacy Study of Intravenous (IV) Elezanumab Assessing Change in Neurologic Function in Adult Pa Acute Ischemic Stroke | Phase 2 | 2020-11-09 |
| Completed | A Study to Assess Infection Rate of Severe Acute Respiratory Syndrome - CoronaVirus 2 (SARS-CoV-2) and It's Af Severe Acute Respiratory Syndrome - CoronaVirus 2 (SARS-CoV-2) | — | 2020-11-05 |
| Terminated | Study to Determine Recommended Phase 2 Dose of Intravenous (IV) Eftozanermin Alfa in Combination With IV or Su Multiple Myeloma | Phase 1 | 2020-11-05 |
| Completed | Study Comparing Continuous Subcutaneous Infusion Of ABBV-951 With Oral Carbidopa/Levodopa Tablets For Treatmen Parkinson's Disease (PD) | Phase 3 | 2020-10-19 |
| Completed | A Study of Oral Upadacitinib Tablets to Assess Treatment Patterns, Achievement of Treatment Targets and Mainte Rheumatoid Arthritis (RA) | — | 2020-10-16 |
| Completed | Study of Oral Glecaprevir/Pibrentasvir Tablets in Participants Aged 12 Years or Older With Chronic Hepatitis C Hepatitis C Virus (HCV) | — | 2020-10-07 |
| Completed | A Study of Oral Upadacitinib Tablets to Assess the Change in Disease Symptoms in Adult Canadian Participants W Rheumatoid Arthritis (RA) | — | 2020-10-07 |
| Completed | A Study of Oral Venetoclax Tablet in Combination With Subcutaneous Low-Dose Cytarabine (LDAC) Injection to Ass Acute Myeloid Leukemia (AML) | Phase 3 | 2020-10-05 |
| Active Not Recruiting | Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn Crohn's Disease (CD) | Phase 3 | 2020-09-30 |
| Completed | Study of Oral Navitoclax Tablet In Combination With Oral Ruxolitinib Tablet When Compared With Oral Ruxolitini Myelofibrosis (MF) | Phase 3 | 2020-09-29 |
| Completed | Study to Assess Effect of Oral Venetoclax Tablet in Combination With Oral Ibrutinib Capsule on Best Overall Re Mantle Cell Lymphoma (MCL) | Phase 2 | 2020-09-23 |
| Completed | Flexible-Dose, Adjunctive Therapy Trial in Adults With Parkinson's Disease With Motor Fluctuations (TEMPO-3) Parkinson Disease | Phase 3 | 2020-09-23 |
| Terminated | A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperpara Chronic Kidney Disease (CKD), Secondary Hyperparathyroidism (SHPT) | Phase 3 | 2020-09-16 |
| Completed | Study to Evaluate the Effect of Different Warm-Up Times of Risankizumab Autoinjector (AI) on the Injection Pai Healthy Volunteers | Phase 1 | 2020-09-15 |
| Active Not Recruiting | Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity I Myelodysplastic Syndrome (MDS) | Phase 3 | 2020-09-10 |
| Completed | Safety And Efficacy Study Of Intravenous (IV) Administration Of Elezanumab To Assess Change In Upper Extremity Spinal Cord Injury (SCI) | Phase 2 | 2020-09-06 |
| Completed | Study of Intravenous and Subcutaneous Administration of Risankizumab in Healthy Participants Healthy Volunteers | Phase 1 | 2020-09-01 |
| Active Not Recruiting | Study of Oral Navitoclax Tablet in Combination With Oral Ruxolitinib Tablet Versus Best Available Therapy to A Myelofibrosis (MF) | Phase 3 | 2020-08-31 |
| Active Not Recruiting | RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Neovascular Age-Related Ma Neovascular Age-Related Macular Degeneration (nAMD) | Phase 2 | 2020-08-25 |
| Completed | Study to Evaluate Oral Ubrogepant in the Acute Treatment of Migraine During the Prodrome in Adult Participants Migraine | Phase 3 | 2020-08-21 |
| Active Not Recruiting | Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysm Endometriosis | Phase 3 | 2020-08-10 |
| Completed | Study to Assess the Safety and Change in Disease Symptoms of Risankizumab (Skyrizi) in Adult Participants With Psoriasis, Psoriatic Arthritis | — | 2020-08-04 |
| Terminated | Phase 1/2 Study of AGN-241622 in Healthy Participants and Participants With Presbyopia Presbyopia | Phase 1 / Phase 2 | 2020-07-27 |
| Completed | A Study of the Safety of Oral Elsubrutinib Capsules and Oral Upadacitinib Tablets Given Alone or in Combinatio Systemic Lupus Erythematosus (SLE) | Phase 2 | 2020-07-27 |
| Completed | Study of Subcutaneous Risankizumab Injection to Assess Change in Palmoplantar Pustulosis Area and Severity Ind Palmoplantar Pustulosis (PPP) | Phase 3 | 2020-07-20 |
| Completed | A Study of Subcutaneous Risankizumab Injection for Pediatric Participants With Moderate to Severe Plaque Psori Psoriasis | Phase 3 | 2020-07-14 |
| Completed | A Study of Oral Upadacitinib Tablet Compared to Placebo in Adult Participants With Moderate to Severe Hidraden Hidradenitis Suppurativa (HS) | Phase 2 | 2020-07-14 |
| Terminated | A Safety Study of Oral Venetoclax in Combination With Intravenous Pembrolizumab in Adult Participants With Pre Non Small Cell Lung Cancer, Cancer | Phase 1 | 2020-06-30 |
| Completed | Cariprazine Pediatric ASD PK Study Autism Spectrum Disorder | Phase 1 | 2020-06-26 |
| Completed | A Study Evaluating Oral Atogepant for the Prevention of Migraine in Japanese Participants With Chronic or Epis Chronic Migraine, Episodic Migraine | Phase 3 | 2020-06-18 |
| Completed | A Phase 3b Study Evaluating the 24-Hour Intraocular Pressure Lowering Effect of Bimatoprost SR in Patients Wit Open-Angle Glaucoma, Ocular Hypertension | Phase 3 | 2020-06-11 |
| Active Not Recruiting | Extension Study To Evaluate Safety And Tolerability Of 24-Hour Daily Exposure Of Continuous Subcutaneous Infus Parkinson's Disease (PD) | Phase 3 | 2020-06-08 |
| Completed | Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With Severe Acute Respira CoronaVirus Induced Disease-2019 (COVID-19) | Phase 2 | 2020-06-06 |
| Completed | First In Human Study With ABBV-CLS-579 When Given Alone and In Combination In Participants With Locally Advanc Advanced Solid Tumors Cancer | Phase 1 | 2020-06-03 |
| Completed | Efficacy Study Of Oral Glecaprevir/Pibrentasvir Tablet In Pediatric (12 Years and Older) And Adult Treatment-N Hepatitis C Virus (HCV) | — | 2020-05-29 |
| Completed | A Study to Evaluate the Effect of Intravenous (IV) Infusions of Risankizumab on Pharmacokinetics of Cytochome Ulcerative Colitis (UC), Crohn's Disease | Phase 1 | 2020-05-27 |
| Completed | A Study Describing the Care Cascade and Effectiveness and Safety of Glecaprevir/Pibrentasvir in Adult Particip Hepatitis C Virus (HCV) | — | 2020-05-26 |
| Terminated | A Study to Evaluate the Safety and Tolerability of Venetoclax Tablets in Combination With Capecitabine Tablets Breast Cancer, Cancer | Phase 1 | 2020-05-21 |
| Terminated | A Study of the Safety and Tolerability of ABBV-467 in Adult Participants With Relapsed/Refractory (R/R) Multip Multiple Myeloma (MM), Cancer | Phase 1 | 2020-05-19 |
| Completed | A Study of the Effect of Topical Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants Hypogonadism | Phase 4 | 2020-05-12 |
| Withdrawn | Study Of Effects Of Oral CREON Capsules In Adult Participants With Exocrine Pancreatic Insufficiency Not Due T Exocrine Pancreatic Insufficiency (EPI) | Phase 4 | 2020-05-06 |
| Terminated | A Study to Determine Safety, Tolerability, Pharmacokinetics, and Recommended Phase 2 Dose (RP2D) of Intravenou Acute Myeloid Leukemia (AML), Non Small Cell Lung Cancer, Cancer | Phase 1 | 2020-05-05 |
| Completed | Study To Assess Frequency Of Serious Infections In Clinical Practice In Japan For Adult Participants With Rheu Rheumatoid Arthritis (RA) | — | 2020-04-24 |
| Completed | A Study of the Safety and Efficacy of Venetoclax for Participants With Chronic Lymphocytic Leukemia (CLL) Used Cancer, Chronic Lymphocytic Leukemia (CLL) | — | 2020-04-02 |
| Completed | A Study of Oral Venetoclax Tablets and Oral Azacitidine as Maintenance Therapy in Adult Participants With Acut Acute Myeloid Leukemia (AML) | Phase 3 | 2020-03-26 |
| Completed | A Study of the Effectiveness of Venetoclax Tablets in Adult Acute Myeloid Leukemia Participants Ineligible for Acute Myeloid Leukemia (AML) | — | 2020-03-13 |
| Withdrawn | An Efficacy and Safety Study of Injectable Ravagalimab to Assess Change in EULAR Sjogren's Syndrome Disease Ac Sjogren's Syndrome (SS) | Phase 2 | 2020-03-06 |
| Completed | A Study of the Drugs AGN-242428 and AGN-231868 in Participants With Dry Eye Disease Dry Eye Disease, Dry Eye Syndrome | Phase 1 / Phase 2 | 2020-03-04 |
| Withdrawn | A Study to Evaluate the Safety and Tolerability of ABBV-0805 in Patients With Parkinson's Disease Parkinson's Disease | Phase 1 | 2020-03-03 |
| Terminated | A Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine Versus Standard of Care A Acute Myeloid Leukemia (AML), Cancer | Phase 3 | 2020-02-26 |
| Terminated | A Study of Creon (Pancrelipase) in Resected and Non-resected Pancreatic Cancer Participants With Exocrine Panc Exocrine Pancreatic Insufficiency (EPI) | Phase 4 | 2020-02-25 |
| Completed | A Study of the Effectiveness and Clinical Practice Use of Glecaprevir/Pibrentasvir in Adolescents With Chronic Hepatitis C Virus (HCV) | — | 2020-02-17 |
| Terminated | A Non-Drug Study Detecting And Quantifying Nocturnal Scratch Behaviors From Wrist Actigraphy Data In Adult Hea Atopic Dermatitis | Phase 1 | 2020-02-17 |
| Active Not Recruiting | An Efficacy and Safety Study of Cofetuzumab Pelidotin in Participants With PTK7-Expressing, Recurrent Non-Smal Cancer, Non-small Cell Lung Cancer (NSCLC) | Phase 1 | 2020-02-13 |
| Completed | An Observational Study to Evaluate Impact of CRP-Level on Real World Effectiveness of Upadacitinib as Monother Rheumatoid Arthritis (RA) | — | 2020-02-06 |
| Active Not Recruiting | A Study to Evaluate the Efficacy and Safety of Upadacitinib in Participants With Takayasu Arteritis (TAK) Takayasu Arteritis (TAK) | Phase 3 | 2020-02-04 |
| Completed | A Study of the Safety and Efficacy of Venetoclax in Japanese Participants With Relapsed and Refractory Chronic Cancer, Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Leukemia (SLL) | — | 2020-02-03 |
| Completed | A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of ABBV-181 (Budigalimab) in Adult Parti Human Immunodeficiency Virus (HIV), HIV Infection, HIV-1 | Phase 1 | 2020-01-30 |
| Completed | A Trial of the Efficacy and Safety of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures Seizures | Phase 2 | 2020-01-27 |
| Terminated | A Study to Assess the Effects of Multiple Study Drug Regimens in Subjects With Newly Diagnosed Locally Advance Head and Neck Cancer | Phase 1 | 2020-01-22 |
| Completed | A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-368 Plus Til Advanced Solid Tumors Cancer | Phase 1 | 2020-01-22 |
| Terminated | A Study of Women Receiving Standard of Care (SOC) for the Treatment of Pelvic Pain Due to Suspected or Confirm Endometriosis, Chronic Pelvic Pain, Dysmenorrhea | — | 2020-01-20 |
| Completed | Open-Label Extension Study of Upadacitinib in Adult Participants With Moderate to Severe Atopic Dermatitis Atopic Dermatitis | Phase 3 | 2020-01-15 |
| Completed | A Study Evaluating the Efficacy of Venetoclax Plus Ibrutinib in Participants With T-cell Prolymphocytic Leukem Leukemia, T-cell Prolymphocytic Leukemia (T-PLL), Cancer | Phase 2 | 2020-01-14 |
| Active Not Recruiting | A Study of Clinical Outcomes in Chronic Lymphocytic Leukemia (CLL) Patients Treated With Venetoclax in Greece Chronic Lymphocytic Leukemia | — | 2020-01-13 |
| Completed | Flexible-Dose Trial in Early Parkinson's Disease (PD) Parkinson Disease | Phase 3 | 2020-01-06 |
| Completed | A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Adv Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer | Phase 3 | 2019-12-31 |
| Completed | A Study of the Safety, Effectiveness and Clinical Use of Maviret in Adolescent Patients With Chronic Hepatitis Hepatitis C Virus (HCV) | — | 2019-12-26 |
| Completed | Fixed-Dose Trial in Early Parkinson's Disease (PD) Parkinson Disease | Phase 3 | 2019-12-13 |
| Completed | A Phase 2 Study of ABBV-3067 Alone and in Combination With ABBV-2222 Cystic Fibrosis | Phase 2 | 2019-12-11 |
| Completed | Real-World Experience Study of Elagolix For the Treatment of Endometriosis in Canada Endometriosis | — | 2019-12-04 |
| Completed | A Study to Evaluate Efficacy and Safety of Upadacitinib in Adults With Axial Spondyloarthritis Spondyloarthritis | Phase 3 | 2019-11-26 |
| Completed | Long-term Safety of Linaclotide in Pediatric Participants With FC or IBS-C Irritable Bowel Syndrome With Constipation, Functional Constipation | Phase 3 | 2019-11-19 |
| Completed | A Study of the Safety and Efficacy of Risankizumab in Adult Participants With Plaque Psoriasis Who Have Had a Plaque Psoriasis | Phase 3 | 2019-11-12 |
| Active Not Recruiting | A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination Myeloproliferative Neoplasm | Phase 1 | 2019-11-08 |
| Active Not Recruiting | IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Participants With CD123-Positive Acute Myeloi Acute Myeloid Leukemia | Phase 1 / Phase 2 | 2019-11-06 |
| Terminated | A Study to Assess Effectiveness and Safety of Fixed Dose Combination of Lopinavir/Ritonavir (LPV/r) in Human I HIV-1 Infection | — | 2019-11-01 |
| Completed | A Study to Compare US Marketed Creon Manufactured With a Modernized Process at an Alternate Manufacturing Site Cystic Fibrosis | Phase 4 | 2019-10-23 |
| Completed | Linaclotide Safety and Efficacy in Pediatric Participants, 6 to 17 Years of Age, With Irritable Bowel Syndrome Functional Constipation, Irritable Bowel Syndrome With Constipation | Phase 3 | 2019-10-01 |
| Active Not Recruiting | An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, Multiple Myeloma | Phase 3 | 2019-09-06 |
| Completed | BOTOX® Treatment for Adults With a Wide Lower Face Due to Masseter Muscle Prominence Masseter Muscle Prominence | Phase 3 | 2019-08-29 |
| Completed | A Study of the Effectiveness of Venetoclax in Combination With Azacitidine or Decitabine in an Outpatient Sett Acute Myeloid Leukemia (AML), Cancer | Phase 3 | 2019-08-15 |
| Completed | Study of the Safety and Efficacy of Elagolix in Women With Polycystic Ovary Syndrome Polycystic Ovary Syndrome | Phase 2 | 2019-08-12 |
| Active Not Recruiting | A Study to Describe the Safety and Effectiveness of Venetoclax in Acute Myeloid Leukemia (AML) Patients (REVIV Acute Myeloid Leukemia | — | 2019-08-08 |
| Recruiting | A Study to Assess the Effect of Venetoclax on Ethinyl Estradiol and Levonorgestrel in Female Participants With Hematologic Malignancies | Phase 1 | 2019-07-30 |
| Completed | A Study to Investigate the Safety and Efficacy of Elsubrutinib and Upadacitinib Given Alone or in Combination Systemic Lupus Erythematosus (SLE) | Phase 2 | 2019-07-25 |
| Completed | Observational Study of Patients With Moderate to Severe Chronic Plaque Psoriasis Chronic Plaque Psoriasis | — | 2019-07-01 |
| Completed | A Study of Intravenously (IV) Infused or Subcutaneously (SC) Injected Risankizumab in Healthy Adult Participan Healthy Volunteers | Phase 1 | 2019-06-27 |
| Completed | Post-Marketing Surveillance Study of Adalimumab in Pediatric Chronic Severe Plaque Psoriasis Patients in Korea Psoriasis | — | 2019-06-25 |
| Active Not Recruiting | A Study of TNB-383B in Participants With Relapsed or Refractory Multiple Myeloma Multiple Myeloma | Phase 1 / Phase 2 | 2019-06-24 |
| Active Not Recruiting | A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Upadacitinib in Pediatric Subjects With Juvenile Idiopathic Arthritis (JIA) | Phase 1 | 2019-06-24 |
| Completed | A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-157 in Healthy Volunteers and in Par Psoriasis | Phase 1 | 2019-06-11 |
| Completed | A Study to Assess Usability of Risankizumab Autoinjector Combination Product in Participants With Moderate to Psoriasis | Phase 3 | 2019-06-04 |
| Completed | A Global Study Comparing Risankizumab to Placebo in Adult Participants With Moderate to Severe Hidradenitis Su Hidradenitis Suppurativa | Phase 2 | 2019-06-03 |
| Enrolling By Invitation | Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy Neovascular Age-related Macular Degeneration, Wet Macular Degeneration | Phase 2 | 2019-05-31 |
| Completed | A Study of Escitalopram in the Treatment of Children and Adolescents With Generalized Anxiety Disorder Anxiety Disorders,Generalized Anxiety Disorder | Phase 4 | 2019-05-30 |
| Active Not Recruiting | A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-927 With ABB Cancer, Advanced Solid Tumors, Triple-Negative Breast Cancer (TNBC) | Phase 1 | 2019-05-21 |
| Terminated | A Study in Rheumatoid Arthritis Patients Who Have Completed a Preceding Study With ABBV-105 Given Alone or in Rheumatoid Arthritis (RA) | Phase 2 | 2019-05-13 |
| Completed | A Study to Assess Safety and Efficacy of Risankizumab Using a New Formulation in Participants With Moderate to Psoriasis | Phase 3 | 2019-05-13 |
| Completed | Observational Study Evaluating Long-Term Safety and Effectiveness of Humira in Patients With Hidradenitis Supp Hidradenitis Suppurativa (HS) | — | 2019-05-02 |
| Completed | A Study to Evaluate the Safety and Tolerability of ABBV-951 in Subjects With Parkinson's Disease (PD) Parkinson's Disease (PD) | Phase 3 | 2019-04-29 |
| Withdrawn | A Study of Venetoclax Plus Lenalidomide and Dexamethasone for the Treatment of Newly Diagnosed t(11;14)-Positi Multiple Myeloma | Phase 2 | 2019-04-29 |
| Completed | A Study to Evaluate the Safety and Efficacy of Elagolix for the Management of Heavy Menstrual Bleeding Associa Uterine Fibroids | Phase 4 | 2019-04-12 |
| Completed | A Study to Evaluate the Bioavailability of Risankizumab in Pre-filled Syringe or Auto-injector in Healthy Adul Healthy Volunteers | Phase 1 | 2019-04-02 |
| Completed | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ABBV-3373 in Participants With Rheumatoid Arthritis (RA) | Phase 2 | 2019-03-27 |
| Active Not Recruiting | Long-term Safety and Efficacy Extension Trial of Bimatoprost SR Open-Angle Glaucoma, Ocular Hypertension | Phase 3 | 2019-03-27 |
| Completed | A Study to Investigate How Well Ravagalimab (ABBV-323) Works and How Safe it is in Participants With Moderate Ulcerative Colitis (UC) | Phase 2 | 2019-03-26 |
| Active Not Recruiting | A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Have a His Psoriatic Arthritis | Phase 3 | 2019-03-25 |
| Terminated | An Extension Study of ABBV-8E12 in Early Alzheimer's Disease (AD) Alzheimer's Disease | Phase 2 | 2019-03-22 |
| Terminated | A Study of Venetoclax and AMG 176 in Patients With Relapsed/Refractory Hematologic Malignancies Acute Myeloid Leukemia, Non-Hodgkin's Lymphoma, Diffuse Large B-cell Lymphoma | Phase 1 | 2019-03-18 |
| Completed | A Single Ascending Oral Dose Study of SDI-118 in Healthy Male Subjects Including an Assessment of Receptor Occ Cognitive Disorders | Phase 1 | 2019-03-14 |
| Active Not Recruiting | A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Psoriatic Arthritis (PsA) | Phase 3 | 2019-03-07 |
| Completed | Botulinum Toxin Type A (AGN-151607) for the Prevention of Post-operative Atrial Fibrillation in Adult Particip Post-Operative Atrial Fibrillation | Phase 2 | 2019-03-01 |